I-G Investment Management LTD Lifted By $729,000 Its Mattel (MAT) Position; Amedisys (AMED) Sentiment Is 1.75

September 9, 2017 - By Winifred Garcia

Amedisys, Inc. is a healthcare services company. The company has market cap of $1.75 billion. The Company’s divisions are Home Health, Hospice, Personal Care and Other. It has a 44.11 P/E ratio. The Firm is a well-known provider of home health, hospice and personal care services.

I-G Investment Management Ltd increased Mattel Inc (MAT) stake by 54% reported in 2016Q4 SEC filing. I-G Investment Management Ltd acquired 27,000 shares as Mattel Inc (MAT)’s stock declined 15.13%. The I-G Investment Management Ltd holds 77,000 shares with $2.12M value, up from 50,000 last quarter. Mattel Inc now has $4.94B valuation. The stock decreased 1.80% or $0.28 on September 8, reaching $15.28. About 5.76M shares traded. Mattel, Inc. (NASDAQ:MAT) has declined 26.92% since September 9, 2016 and is downtrending. It has underperformed by 43.62% the S&P500.

I-G Investment Management Ltd decreased Pepsico Inc (NYSE:PEP) stake by 302,020 shares to 941,204 valued at $98.48M in 2016Q4. It also reduced Hudbay Minerals Inc (NYSE:HBM) stake by 105,000 shares and now owns 1.55M shares. Pvh Corp (NYSE:PVH) was reduced too.

Investors sentiment decreased to 0.98 in 2016 Q4. Its down 0.10, from 1.08 in 2016Q3. It is negative, as 56 investors sold MAT shares while 159 reduced holdings. 61 funds opened positions while 188 raised stakes. 323.62 million shares or 2.64% more from 315.31 million shares in 2016Q3 were reported. 25,929 are held by Charter Tru Co. City owns 0% invested in Mattel, Inc. (NASDAQ:MAT) for 50 shares. Banque Pictet & Cie reported 0.01% stake. Guinness Atkinson Asset Mgmt Inc reported 0.15% in Mattel, Inc. (NASDAQ:MAT). Cannell Peter B And Company reported 0.01% stake. Baker Avenue Asset Mngmt Limited Partnership holds 0.22% of its portfolio in Mattel, Inc. (NASDAQ:MAT) for 57,969 shares. Pettyjohn Wood And White accumulated 41,630 shares. Barclays Public Lc holds 0.02% or 806,847 shares. Zurcher Kantonalbank (Zurich Cantonalbank) holds 0.04% or 144,470 shares. Bluemountain Capital Mgmt Ltd Llc invested in 1.29% or 2.51 million shares. Hodges Mgmt reported 0.03% in Mattel, Inc. (NASDAQ:MAT). Allianz Asset Management Ag reported 3.87M shares. Prudential Public Limited Com invested 0.02% of its portfolio in Mattel, Inc. (NASDAQ:MAT). Numeric Investors Ltd Liability Com owns 0.01% invested in Mattel, Inc. (NASDAQ:MAT) for 38,200 shares. Sei Co invested in 0.06% or 464,516 shares.

Among 16 analysts covering Mattel Inc. (NASDAQ:MAT), 9 have Buy rating, 1 Sell and 6 Hold. Therefore 56% are positive. Mattel Inc. had 39 analyst reports since July 28, 2015 according to SRatingsIntel. UBS initiated Mattel, Inc. (NASDAQ:MAT) on Thursday, March 24 with “Buy” rating. DA Davidson downgraded the stock to “Underperform” rating in Thursday, August 3 report. The stock of Mattel, Inc. (NASDAQ:MAT) earned “Outperform” rating by Oppenheimer on Thursday, August 20. On Friday, January 27 the stock rating was maintained by Stifel Nicolaus with “Hold”. The stock of Mattel, Inc. (NASDAQ:MAT) has “Neutral” rating given on Friday, August 14 by Piper Jaffray. The rating was maintained by BMO Capital Markets with “Buy” on Tuesday, June 6. The rating was maintained by M Partners with “Buy” on Monday, July 3. The firm has “Buy” rating given on Friday, December 4 by Jefferies. BMO Capital Markets maintained it with “Outperform” rating and $25 target in Monday, July 31 report. The company was downgraded on Wednesday, April 6 by Stifel Nicolaus.

Since January 1, 0001, it had 1 buying transaction, and 4 selling transactions for $4.35 million activity.

Kohlberg Kravis Roberts & Co. L.P. holds 3.29% of its portfolio in Amedisys Inc for 4.84 million shares. First Light Asset Management Llc owns 117,279 shares or 2.2% of their US portfolio. Moreover, Tygh Capital Management Inc. has 1.35% invested in the company for 126,242 shares. The New York-based Gilder Gagnon Howe & Co Llc has invested 0.69% in the stock. Cortina Asset Management Llc, a Wisconsin-based fund reported 329,554 shares.

The stock decreased 0.38% or $0.2 on September 8, reaching $51.85. About 205,727 shares traded. Amedisys Inc (AMED) has risen 15.02% since September 9, 2016 and is uptrending. It has underperformed by 1.68% the S&P500.

Ratings analysis reveals 50% of Amedisys’s analysts are positive. Out of 2 Wall Street analysts rating Amedisys, 1 give it “Buy”, 0 “Sell” rating, while 1 recommend “Hold”. The lowest target is $47.0 while the high is $50.0. The stock’s average target of $48.50 is -6.46% below today’s ($51.85) share price. AMED was included in 2 notes of analysts from November 7, 2016. Benchmark initiated the shares of AMED in report on Friday, January 27 with “Hold” rating. The stock of Amedisys Inc (NASDAQ:AMED) has “Buy” rating given on Monday, November 7 by Mizuho.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Twitter Auto Publish Powered By : XYZScripts.com